Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome?
Bouchla, Anthi, Papageorgiou, Sotirios G., Symeonidis, Argyris, Sakellari, Ioanna, Zikos, Panagiotis, Thomopoulos, Thomas P., Hatzimichael, Eleftheria, Galanopoulos, Athanasios, Vyniou, Nora-Athina, Kotsianidis, Ioannis, Pappa, Vasiliki
Published in Leukemia (01.12.2023)
Published in Leukemia (01.12.2023)
Get full text
Journal Article
Evidence that platelets from transfusion-dependent β-thalassemia patients induce T cell activation
Solomou, Elena E., Delaporta, Polyxeni, Mantzou, Aimilia, Tzannoudaki, Marianna, Diamantopoulos, Panagiotis, Salamaliki, Christina, Kontandreopoulou, Christina-Nefeli, Vyniou, Nora-Athina, Perganti, Foteini, Papassotiriou, Ioannis, Kattamis, Antonis
Published in Clinical immunology (Orlando, Fla.) (01.08.2023)
Published in Clinical immunology (Orlando, Fla.) (01.08.2023)
Get full text
Journal Article
Lenalidomide (Len) Refractory MM Patients’ Outcomes
Gkioka, Annita Ioanna, Repousis, Panagiotis, Rougkala, Niki, Asmanis, Evangelos, Bartzi, Vasiliki, Dimou, Maria, Iliakis, Theodoros, Vyniou, Nora Athina, Panayiotidis, Panayiotis, Kyrtsonis, Mariechristine
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article